Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma is a research paper published in medRxiv (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA172404-05
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5K07CA080668-06
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS
National Institutes of Health
Grant: 5R01CA095023-03
Inflammation and Ovarian Cancer
National Institutes of Health
Grant: 5R01CA248288-04
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk
National Institutes of Health
Grant: 4R01CA168758-04
Epidemiologic factors and survival by molecular subtypes of ovarian cancer
National Institutes of Health
Grant: 1R21CA267050-01
Multi-omic Predictive Markers for Ovarian Cancer Therapy Response and Outcomes
Swiss National Science Foundation
Grant: 15083
Helvetia Sacra VII: Der Regularklerus. Die Gesellschaft Jesu in der Schweiz / Die Somasker in der Schweiz
National Health and Medical Research Council (NHMRC)
Grant: 628903
Australasian Biospecimen Network - Oncology
UK Research and Innovation
Grant: MC_UU_00004/01
Evaluating new healthcare technologies in cancer
National Health and Medical Research Council (NHMRC)
Grant: 310670
Australasian Biospecimen Network-Oncology
National Institutes of Health
Grant: 5P50CA136393-10
Mayo Clinic Ovarian Cancer SPORE
National Institutes of Health
Grant: 3P30CA015083-37S2
Mayo Comprehensive Cancer Center Grant
Swiss National Science Foundation
Grant: 222151
Integrated multi-omic and clinicopathological analysis of BRCA-mutated high-grade serous ovarian cancer in patients with poor survival: identification of predictive biomarkers for personalized treatment
NCI NIH HHS
Grant: R21 CA267050
NCI NIH HHS
Grant: R01 CA172404
NCI NIH HHS
Grant: K07 CA080668
NCI NIH HHS
Grant: P30 CA015083
NCI NIH HHS
Grant: R01 CA248288
NCRR NIH HHS
Grant: M01 RR000056
NCI NIH HHS
Grant: R01 CA095023
NCI NIH HHS
Grant: R01 CA168758
NCI NIH HHS
Grant: P30 CA071789
NCI NIH HHS
Grant: P50 CA136393
Fields of Study
Keywords